Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-10-17FDA Approved: XPHOZAH 10 MG — Original Application (Ardelyx, Inc.)
FDA approved XPHOZAH (tenapanor) from Ardelyx in its original NDA for the treatment of hyperphosphatemia in adults with chronic kidney disea…
-
FDA approval · 2023-09-08FDA Approved: SEVELAMER CARBONATE — Original Application (Strides Pharma Science Limited)
FDA approved the original abbreviated new drug application for sevelamer carbonate from Strides Pharma Science Limited, a generic phosphate …
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]
Phase 3 trial update for KHK7791 in hyperphosphatemia patients on hemodialysis has completed.
-
FDA approval · 2023-07-11FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for sevelamer hydrochloride by Aurobindo Pharma Limited, establishing a generic version of the phosphate binde…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis [Phase 3]
Phase 3 trial update for tenapanor in hyperphosphatemia among end-stage renal disease patients on dialysis; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-06-06FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer carbonate from Sanofi-Aventis U.S. LLC, indicating an updated labeling for the product…
-
FDA approval · 2023-05-26FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for sevelamer hydrochloride from Macleods Pharmaceuticals Limited, authorizing a generic phosphate bin…
-
FDA approval · 2023-05-19FDA Approved: SEVELAMER CARBONATE — Supplemental Application (DR. REDDY'S LABORATORIES LIMITED)
FDA approved a supplemental application for Sevelamer Carbonate submitted by Dr. Reddy's Laboratories Limited. Sevelamer carbonate is a phos…
-
FDA approval · 2023-05-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) filed by Takeda Pharmaceuticals America, Inc., expanding the …
-
FDA approval · 2023-05-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: A Study of Ferric Citrate to Improve Inflammation and Lipid Levels [Phase 4]
Phase 4 trial of ferric citrate in end-stage renal disease assesses inflammation and lipid levels; the study was terminated with results pos…
-
FDA approval · 2023-04-19FDA Approved: SEVELAMER CARBONATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's sevelamer carbonate as an original-application generic for treating hyperphosphatemia in pat…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP [Phase 4]
Phase 4 trial evaluating long-term safety and efficacy of Tenapanor alone or with Sevelamer in dialysis patients with hyperphosphatemia and …
-
CLINICAL_TRIALS research · 2023-03-29Clinical Trial Update: Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia [Phase 4]
A Phase 4 trial evaluating tenapanor as core therapy for hyperphosphatemia in chronic kidney disease patients on dialysis has completed with…
-
FDA approval · 2023-03-13FDA Approved: CALCIUM ACETATE — Original Application (SQUARE PHARMACEUTICALS LIMITED)
The FDA approved Square Pharmaceuticals Limited's original application for calcium acetate, making a generic version of this phosphate binde…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy [Phase 2, Phase 3]
A phase 2/3 clinical trial update on tenapanor as an adjunct to phosphate binder therapy for hyperphosphatemia has completed with results po…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants [Phase 4]
Phase 4 trial update of Auryxia (ferric citrate) for in-center and home dialysis patients with hyperphosphatemia, anemia, or iron deficiency…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients [Phase 2]
A Phase 2 clinical trial assessing safety and efficacy of VS-505(AP301) for treating hyperphosphatemia in hemodialysis patients has complete…
-
FDA approval · 2022-07-20FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Lanthanum carbonate.
-
FDA approval · 2022-05-25FDA Approved: SEVELAMER CARBONATE FOR ORAL SUSPENSION — Supplemental Application (Dr. Reddys Laboratories Inc)
FDA approved a supplemental application for Sevelamer carbonate for oral suspension from Dr. Reddy's Laboratories, enabling a generic formul…
-
FDA approval · 2022-04-25FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals' supplemental application for sevelamer carbonate, enabling its generic product to be marketed.…
-
FDA approval · 2022-04-05FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Sevelamer carbonate by Aurobindo Pharma Limited. This approval enables the generic product to be…
-
FDA approval · 2022-02-07FDA Approved: SEVELAMER CARBONATE — Original Application (Micro Labs Limited)
FDA approved the original ANDA for Sevelamer carbonate from Micro Labs Limited, enabling a generic version of the phosphate binder used to t…
-
FDA approval · 2022-01-27FDA Approved: LANTHANUM CARBONATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's lanthanum carbonate generic product for reducing phosphate levels in patients with end-stage renal disease on dialysis. …
-
FDA approval · 2022-01-24FDA Approved: LANTHANUM CARBONATE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic lanthanum carbonate (original application) for the treatment of hyperphosphatemia in adults with chron…